Simsen Diagnostics’ vision is to maximize the potential of ultrasensitive sequencing for improved healthcare and novel applications. Our unique technology enables sensitive detection of cancer mutations by a simple blood sample. This allows precision medicine to be applied to more patients and monitoring of the disease over time. Compared to other technologies for ultrasensitive sequencing, our solutions are both simple to use and specifically adapted for the analysis of difficult to analyze DNA. Customers include laboratories, pharmaceutical companies, and hospitals.